Cancer stem-like cell related protein CD166 degrades through E3 ubiquitin ligase CHIP in head and neck cancer

Our previous studies have identified that CD166 works as a cancer stem-like cell (CSC) marker in epithelial cancers with a large repertoire of cellular functions. However, the post-translational regulatory mechanisms underlying CD166 turnover remain elusive. Several independent studies have reported...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiao, Meng, Yan, Ming, Zhang, Jianjun, Xu, Qin, Qi, Shengcai, Wang, Xu, Chen, Wantao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academic Press 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5381905/
https://www.ncbi.nlm.nih.gov/pubmed/28279658
http://dx.doi.org/10.1016/j.yexcr.2017.03.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5381905/
https://www.ncbi.nlm.nih.gov/pubmed/28279658
http://dx.doi.org/10.1016/j.yexcr.2017.03.005

Ejemplares similares